ID   CUTO-27
AC   CVCL_C8T1
SY   CUTO27; Colorado University Thoracic Oncology 27
DR   GEO; GSM7675361
DR   GEO; GSM7675362
DR   GEO; GSM7675363
DR   GEO; GSM7675364
DR   GEO; GSM7675365
DR   GEO; GSM7675366
DR   Wikidata; Q123030990
RX   PubMed=29636358;
WW   http://cuamc.technologypublisher.com/technology/48354
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (UCSM).
CC   Omics: Transcriptome analysis by RNAseq.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
RX   PubMed=29636358; DOI=10.1158/1078-0432.CCR-17-2452; PMCID=PMC6050099;
RA   McCoach C.E., Le A.T., Gowan K., Jones K.L., Schubert L., Doak A.E.,
RA   Estrada-Bernal A., Davies K.D., Merrick D.T., Bunn P.A. Jr.,
RA   Purcell W.T., Dziadziuszko R., Varella-Garcia M., Aisner D.L.,
RA   Camidge D.R., Doebele R.C.;
RT   "Resistance mechanisms to targeted therapies in ROS1(+) and ALK(+)
RT   non-small cell lung cancer.";
RL   Clin. Cancer Res. 24:3334-3347(2018).
//